Biomarker Tests for Molecularly Targeted Therapies: Laying the Foundation and Fulfilling the Dream [SPECIAL ARTICLE]

This article presents an overview of the committee’s study and resulting recommendations, which cover establishment of clinical utility, regulatory oversight, coverage and reimbursement, health system data integration, as well as education and access. The committee’s recommendations presented and discussed here are fundamentally grounded in the understanding that, when properly validated and appropriately implemented, these assays and corresponding therapies hold considerable promise to enhance the quality of patient care and improve meaningful clinical outcomes.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Tags: Non-ASCO Guidelines, Cancer Biomarkers, Other SPECIAL ARTICLE Source Type: research